Posted by: admin on: May 11, 2011
We all have been using low dose aspirin for prevention of acute vascular events. Now a new meta study shows its utility in lowering mortality due to cancer. Team@CMHF
Posted by: admin on: April 27, 2011
The drug dabigatran is now recommended by some doctors over warfarin in treatment of atrial fibrillation. New guidelines also suggest surgery. According to new guidelines released in the ‘Canadian Journal of Cardiology’ on Feb. 18 2011, warfarin is out and a drug called dabigatran is in when it comes to treating the symptoms of atrial […]
Posted by: admin on: April 26, 2011
It makes little difference to the risk of MI, stroke, or death whether chronic aspirin therapy is discontinued earlier than five days or within five days of CABG surgery Withdrawal of aspirin within five days of surgery in the analysis was associated with greater need for peri- and postoperative transfusion. Later aspirin withdrawal doesn’t necessarily […]
Posted by: admin on: April 18, 2011
Control of cardiovascular (CV) risk factors, particularly hypertension, is still unsatisfactory, resulting in excess CV morbidity and mortality worldwide. CV risk is linearly associated with an increase in blood pressure (BP) values, and clinical studies have clearly demonstrated that BP lowering represents the most effective means of preventing CV events. However, while BP reduction is […]
Posted by: admin on: April 18, 2011
Ischemic heart disease (IHD) is the leading cause of death among women in the Western world, and its prevalence is growing. Women with chest pain and abnormal stress tests are less likely than men to have critical stenosis of coronary arteries, a phenomenon attributed to endothelial dysfunction. Hypertension, intimal injury, and cholesterol are among the […]